Treatment of OCD with Co-occurring Tic Disorder
Start with a selective serotonin reuptake inhibitor (SSRI) or clomipramine as first-line treatment, and if response is inadequate after an adequate trial, add an antipsychotic medication to the antidepressant regimen—this combination shows significantly better efficacy (67% improvement) compared to antidepressant alone in this specific population 1.
Treatment Algorithm
Step 1: Initial Assessment and Psychoeducation
Before initiating pharmacotherapy, conduct a thorough evaluation to:
- Quantify OCD severity using Y-BOCS scoring
- Assess tic severity and frequency
- Identify which symptom cluster (OCD vs tics) causes greater functional impairment
- Screen for additional comorbidities (ADHD, anxiety, depression) 2, 3
Provide comprehensive psychoeducation about the natural history, premonitory urges, and treatment expectations 4, 5.
Step 2: Prioritize Treatment Targets
The presence of OCD with tics fundamentally changes your treatment approach. When both conditions coexist, you must hierarchically determine which symptom cluster to target first based on functional impairment 5, 3.
Step 3: First-Line Pharmacotherapy
Begin with an antidepressant (SSRI or clomipramine). The meta-analysis shows 29% of patients improve with antidepressants alone 1. However, this is notably lower than typical OCD response rates, suggesting this comorbid population is inherently more treatment-resistant.
Step 4: Augmentation Strategy for Inadequate Response
This is the critical decision point. When antidepressants provide insufficient benefit:
- Add an antipsychotic to the existing antidepressant rather than switching medications
- This combination increases improvement rates from 7% (placebo add-on) to 67% (antipsychotic add-on) 1
- The Y-BOCS score reduction is substantially greater with antipsychotic augmentation (-10.06 vs -3.61) 1
Choose anti-dopaminergic medications preferentially when OCD symptoms are prominent, as these agents address both tics and obsessive-compulsive behaviors more effectively than alpha-2-agonists 6. The correlation between OCD comorbidity and anti-dopaminergic medication use reflects their dual efficacy.
Step 5: Behavioral Interventions
Integrate behavioral therapy alongside pharmacotherapy:
- Comprehensive Behavioral Intervention for Tics (CBIT) for tic management 2, 7
- Exposure and Response Prevention (ERP) adapted for OCD symptoms 7
- Consider mindfulness-based interventions, which show specific benefit for reducing OC symptoms in tic disorder patients 8
Critical Clinical Nuances
The OCD phenomenology in tic disorders differs from pure OCD. Obsessions and compulsions may blend with or mimic tics, making symptom boundaries less distinct 9. This overlap explains why standard OCD treatments show lower efficacy rates in this population.
Avoid the common pitfall of treating tics and OCD as separate entities. The neurobiologic substrates overlap significantly, involving cortico-striato-pallido-thalamo-cortical circuit dysregulation 4, 9. This shared pathophysiology supports the rationale for anti-dopaminergic augmentation.
Monitoring Requirements
When using antipsychotic augmentation:
- Monitor for extrapyramidal symptoms
- Assess metabolic parameters (weight, glucose, lipids)
- Evaluate for sedation and cognitive effects
- Conduct periodic reassessment of treatment necessity 5, 2
Refractory Cases
For severe, treatment-refractory cases in adults, deep brain stimulation targeting the subthalamic nucleus (Level I recommendation), nucleus accumbens, or bed nucleus of stria terminalis (Level II recommendation) may be considered 10. For tic-predominant presentations, additional DBS targets include the centromedian-parafascicular thalamus and globus pallidus interna 11.
The evidence strongly supports aggressive pharmacological treatment in this population, as the combination approach addresses the unique neurobiologic profile of OCD comorbid with tics more effectively than monotherapy.